As a prototype preventive molecular tool, very recently we employed the Fab segment of the inhouse-generated rat antiHGF mAb 1H41C10 (IgG2a()), raised against the synthetic peptide FTSNPEVR nitro Y 198 EV, a sequence highly conserved among mammals
Maddy Baier, sophomore, Deans List, College of Education and Human Sciences, child, youth and family studies
Dysbiosis of the gut microbiota is now recognized as a critical factor in both the initiation and progression of IBD ( 5-Aminosalicylic acid (5-ASA) remains a cornerstone of IBD therapy ( Natural polysaccharides have demonstrated considerable benefits in IBD treatment, as they reduce drug-related side effects while enhancing therapeutic efficacy ( Additionally, polysaccharide-based nanoparticles have attracted attention for their ability to improve drug stability and sustain therapeutic activity ( 2 The relationship between the intestinal microbiome and IBD Numerous studies have documented significant alterations in the intestinal microbiota of patients with IBD compared with healthy individuals ( For example, one study reported markedly reduced levels of anti-inflammatory taxa such as Faecalibacterium prausnitzii , Bifidobacterium adolescentis , and other beneficial species in CD patients, alongside a significant increase in the pro-inflammatory species Ruminococcus gnavus ( Shigella , Aeromonas , Clostridium , Sutterella , and Akkermansia muciniphila
Diabetes 116, 600605 (2008)
Banton S, von Massow M, Pezzali JG, Verbrugghe A, Shoveller AK
Wijnants et al., 2022)
